VANCOUVER, BC – NervGen Pharma Corp. (TSX-V: NGEN) (OTCQX: NGENF) (“NervGen” or the “Company”), a clinical stage biotech company dedicated to creating innovative treatments for nervous system damage, today announced the formation of… Read More
Total investment of EUR 90 million Smart factory will further speed the market launch of innovative drugs Boosts pharmaceutical production in Germany and Europe INGELHEIM, GER – Rhineland-Palatinate Minister President Malu… Read More
GenEp Raises $1.45 Million Seed Financing GenEp, Inc., a biotechnology company developing therapies that address unmet needs in patients with epilepsy, announced today the closing of a $1.45 million seed… Read More
Event: Approaches & Challenges in Choosing the Right Translational Oncology Indication Presented by: Zaki Sellam, Gary Brandam, Emmanuel Grillot, Alex Moreau Date & Time: Wednesday, October 27, 2021 | 11:00… Read More
TORONTO, ON – Minimally invasive image-guided therapy start-up, SpinaFX Medical Inc. (SpinaFX) is pleased to announce the signing of a commercialization contract manufacturing agreement with StarFish Product Engineering Inc. (“StarFish Medical”), Canada’s largest medical… Read More
